Evidence map›Paper›PMID 25217627›Full record

ArticleJournal of cell science2014

Endocytic trafficking of laminin is controlled by dystroglycan and is disrupted in cancers.

Dmitri Leonoudakis, Ge Huang, Armin Akhavan, Jimmie E Fata, Manisha Singh, Joe W Gray, John L Muschler

Abstract read
In one paragraph

Article in Journal of cell science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Targeted Drug Delivery via the Use of ECM-Mimetic Materials.Frontiers in bioengineering and biotechnology · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Lysosomes in cancer-living on the edge (of the cell).Current opinion in cell biology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Dmitri LeonoudakisCalifornia Pacific Medical Center Research Institute, 475 Brannan St., Suite 220, San Francisco, CA 94107, USA.
Ge HuangBiomedical Engineering Department, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
Armin AkhavanCalifornia Pacific Medical Center Research Institute, 475 Brannan St., Suite 220, San Francisco, CA 94107, USA.
Jimmie E FataDepartment of Biology, College of Staten Island, City University of New York, 2800 Victory Blvd, Staten Island, NY 10314, USA.
Manisha SinghCalifornia Pacific Medical Center Research Institute, 475 Brannan St., Suite 220, San Francisco, CA 94107, USA.
Joe W GrayBiomedical Engineering Department, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA Center for Spatial Systems Biomedicine, and Knight Cancer Institute, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
John L MuschlerCalifornia Pacific Medical Center Research Institute, 475 Brannan St., Suite 220, San Francisco, CA 94107, USA Biomedical Engineering Department, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA muschler@ohsu.edu.
California Pacific Medical Center · USOregon Health & Science University · USCity University of New York · US

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Tissue and Outcomes CoreP50CA058207 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRAY, JOE W. · 1992 to 2012
$32.7M
Oregon Clinical and Translational Research InstituteUL1TR000128 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLISON, DAVID H · 2012 to 2015
$28.7M
Systems-Based Predictions of Responses to Cancer TherapyU54CA112970 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI TOMLIN, CLAIRE J · 2004 to 2014
$27.1M
Dystroglycan in Epithelial Architecture and FunctionR01CA109579 · NCI · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI MUSCHLER, JOHN L · 2005 to 2009
$1.6M
NCATS NIH HHS UL1 TR000128NCI NIH HHS P30 CA069533NCI NIH HHS P50 CA058207NCI NIH HHS R01 CA109579NCI NIH HHS U54 CA112970
6 · The paper itself

Abstract

The dynamic interactions between cells and basement membranes serve as essential regulators of tissue architecture and function in metazoans, and perturbation of these interactions contributes to the progression of a wide range of human diseases, including cancers. Here, we reveal the pathway and mechanism for the endocytic trafficking of a prominent basement membrane protein, laminin-111 (referred to here as laminin), and their disruption in disease. Live-cell imaging of epithelial cells revealed pronounced internalization of laminin into endocytic vesicles. Laminin internalization was receptor mediated and dynamin dependent, and laminin proceeded to the lysosome through the late endosome. Manipulation of laminin receptor expression revealed that the dominant regulator of laminin internalization is dystroglycan, a laminin receptor that is functionally perturbed in muscular dystrophies and in many cancers. Correspondingly, laminin internalization was found to be deficient in aggressive cancer cells displaying non-functional dystroglycan, and restoration of dystroglycan function strongly enhanced the endocytosis of laminin in both breast cancer and glioblastoma cells. These results establish previously unrecognized mechanisms for the modulation of cell-basement-membrane communication in normal cells and identify a profound disruption of endocytic laminin trafficking in aggressive cancer subtypes.

Indexed as

AnimalsBasement MembraneDystroglycansEndocytosisFemaleHumansLamininMammary Glands, AnimalMammary Glands, HumanMiceMice, KnockoutNeoplasmsPregnancyDystroglycansLamininCancerDystroglycanEndocytosisLaminin

Identifiers

PMID25217627
PMCPMC4231305
OpenAlexW2074035138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.